semaglutide + tirzepatide 💉WHAT HAPPENS AFTER STOPPING WEIGHT-LOSS DRUGS Clinical trials show many patients regain a portion of the weight they lost after discontinuing medications such as and tirzepatide, raising questions about long-term treatment The GLP-1 Muscle Loss Scare:

These drugs mimic the action of a natural hormone called glucagon-like peptide-1 (GLP-1) in the body

Patients may notice return of hyperglycemia symptoms such as increased thirst, frequent urination, and fatigue

Option Cagrilintide Evidence for the added compound Human Phase 2 data alone and Phase 3 data with semaglutide Evidence for the retatrutide combination None identified Option Tesamorelin Evidence for the added compound Randomized trials and an FDA-approved narrow indication Evidence for the retatrutide combination None identified Option CJC-1295 + ipamorelin Evidence for the added compound Small human studies showing GH or IGF-1 response Evidence for the retatrutide combination None identified Option MOTS-C Evidence for the added compound Human observational biology plus mostly preclinical treatment research Evidence for the retatrutide combination None identified This ranking describes research depth

A., & Mbah, J